Cite

HARVARD Citation

    Gravia, A. et al. (2016). Correlation of SIN3A genomic variants with β-hemoglobinopathies disease severity and hydroxyurea treatment efficacy. Pharmacogenomics. pp. 1785-1793. [Online]. 
  
Back to record